HK1244484B - 藥物化合物nxl104的多晶型形式和假多晶型形式 - Google Patents

藥物化合物nxl104的多晶型形式和假多晶型形式

Info

Publication number
HK1244484B
HK1244484B HK18103892.3A HK18103892A HK1244484B HK 1244484 B HK1244484 B HK 1244484B HK 18103892 A HK18103892 A HK 18103892A HK 1244484 B HK1244484 B HK 1244484B
Authority
HK
Hong Kong
Prior art keywords
nxl104
polymorphic
pharmaceutical compound
pseudopolymorphic forms
pseudopolymorphic
Prior art date
Application number
HK18103892.3A
Other languages
English (en)
Inventor
Sisir Bhattacharya
Alain Bonnet
Mahendra G Dedhiya
Véronique Ducandas
Alexandre Giuliani
Alain Priour
Valérie Ravaux
Peter Spargo
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0904864A external-priority patent/FR2951171A1/fr
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of HK1244484B publication Critical patent/HK1244484B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
HK18103892.3A 2009-10-09 2018-03-21 藥物化合物nxl104的多晶型形式和假多晶型形式 HK1244484B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0904864A FR2951171A1 (fr) 2009-10-09 2009-10-09 Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
US26366309P 2009-11-23 2009-11-23

Publications (1)

Publication Number Publication Date
HK1244484B true HK1244484B (zh) 2019-11-08

Family

ID=71138449

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103892.3A HK1244484B (zh) 2009-10-09 2018-03-21 藥物化合物nxl104的多晶型形式和假多晶型形式

Country Status (2)

Country Link
HK (1) HK1244484B (zh)
IL (1) IL286555A (zh)

Also Published As

Publication number Publication date
IL286555A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
HUE043086T2 (hu) Az NXL104 gyógyszerészeti vegyület polimorf és pszeudopolimorf formái
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
HK1175470A1 (zh) 六氫茚並吡啶和八氫苯並喹啉的芳基-和雜芳基羰基衍生物
EP2515713A4 (en) STABILIZATION OF OBJECTS
IL258239A (en) and st–methods producing polymorphs of 246 for their preparation
EP2438246A4 (en) CONSTRUCTION ASPECTS
EP2381786A4 (en) DARUNAVIR POLYMORPHS
GB2474075B (en) Display assembly having different types of display
GB0915515D0 (en) Treatment of vasculoproliferative conditions
EP2231687A4 (en) NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES
EP2515709A4 (en) STABILIZATION OF OBJECTS
EP2400848A4 (en) CRYSTALLIZATION OF PHARMACEUTICAL COMPOUNDS
EP2490541A4 (en) 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE
EP2415774A4 (en) PRASUGREL BROMHYDRATE CRYSTALS
EP2478359A4 (en) METHOD FOR IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
GB0910078D0 (en) Uses of mannose-6-phosphate
HK1244484B (zh) 藥物化合物nxl104的多晶型形式和假多晶型形式
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE
TWM372743U (en) Improved structure of Kendama
EP2404608A4 (en) COMBINATION USE OF CHOLESTANOL DERIVATIVE
TWM365675U (en) Improved structure of teapoy
GB0920625D0 (en) Ace of plugs
GB0821710D0 (en) Derivatives of dihydroindolone

Legal Events

Date Code Title Description
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)